Back to results
US 7,125,871 B2Granted
Excitatory amino acid receptor modulators
AssigneeEli Lilly and Company
InventorsIvan Collado Cano, Jesus Ezquerra-Carrera, Alicia Marcos Liorente, Luisa Maria Martin-Cabrejas, James Allen Monn
Life of this patent
Estimating the term…
Abstract
Compounds of the formula (I) in which R1, R2 and X1 have the meanings given in the specification, modulate metabotropic glutamate receptor function and are useful in treating disorders of the central nervous system
Claims10
A compound of the formula:
- in which:
- R represents CN or a group of formula CONR1(X1R2);
- X1 represents a bond, NHCO, NH, O or (CH2)p—Y— in which Y represents O, S, NRb, or COO and p is 2 or 3, and R1, R2 and Rb each independently represents hydrogen;
- C1-10 alkyl;
- C2-10 alkenyl;
- C2-10 alkynyl;
- aryl;
- aryl-C1-10 alkyl;
- aryl -C2-10 alkenyl;
- aryl-C2-10 alkynyl;
- heteroaryl;
- C3-8 cycloalkyl;
- C3-8-cycloalkyl-C1-10 alkyl;
- a group of formula CH(R3)COOH in which R3 represents an amino acid residue;
- or R1 and X1R2 together with the nitrogen atom to which they are attached form a 5 to 6-membered saturated heterocyclic ring, which ring may optionally be fused with an aromatic ring;
- an ester thereof;
- or a salt of said compound of formula I or said ester thereof.
14 more elements
Dependencies are inferred from the claim text.